HEALTHX Health X Platform (HEALTHX) Q4 FY25 results (Jan–Mar 2025) and concall
Sastasundar Ventures Limited reported a transitional FY25, marked by a strategic reset post-Flipkart Health. While the B2C segment faced headwinds, the RetailerShakti B2B business demonstrated robust growth, nearly doubling revenue. The company achieved significant improvements in working capital efficiency and maintains strong liquidity, despite reporting negative EBITDA for the year. Management outlined plans for accelerated B2C growth, profitability targets for RetailerShakti, and continued investment in technology and platform development.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 |
|---|---|---|---|
| Revenue | 0 | 0 | 0 |
| EBITDA | -0 | -0 | -0 |
| Net profit | -0 | -0 | -0 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
